National IV Fluids Shortage FAQ
A shortage of IV fluids is impacting hospitals and health systems nationwide, including UW Medicine. Our priority is ensuring that our patients continue to receive high quality care. Our facilities are open and we are actively managing our supply to ensure our patients receive IV fluids when needed.
Most care at UW Medicine will not be affected by the shortage, but our hospitals are taking steps to safely conserve supply, including rescheduling some less time-sensitive procedures and following expert state and national guidance in the way we deliver care in order to conserve IV solution. If there are any changes to your appointments, we will reach out proactively. Thank you for your understanding.
Frequently asked questions
Should I still come in for my appointment or go to the hospital?
Yes. Our highest priority is ensuring our patients continue to get the care they need. We are safely managing our supply, and all facilities remain open. We will notify patients if there are any changes to their appointments. If you are scheduled for surgery or another procedure, you should plan to keep that appointment unless otherwise notified. If you have specific care-related questions, please contact your provider.
What are IV fluids?
IV fluids are liquids administered directly into a patient’s vein. They are used to replace fluids and electrolytes in patients for various medical treatments including hydration and medication delivery, particularly when oral intake is not possible or sufficient, as well as other critical care needs.
What is UW Medicine doing to mitigate the impacts of the shortage?
All patients who need IV fluids are still receiving them. We are safely conserving our IV and irrigation fluid supply across our system when medically appropriate by closely monitoring fluid use and using smaller amounts or administering oral hydration (i.e., drinking liquids).
What is causing the IV and irrigation fluid shortage?
The shortage was caused when Hurricane Helene damaged Baxter’s North Carolina manufacturing plant which produces about 60 percent of the IV solution used in the United States.
How long will this shortage last?
This North Carolina facility is not expected to return to full production until at least the end of 2024.